Particella Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Later Stage VC
- Investors
-
17
Particella General Information
Description
Developer of an oral lipid nanoparticle technology designed to deliver nucleic acids to the intestinal epithelium. The company focuses on oral mRNA medicines with repeatable dosing and non-immunogenic properties, enabling healthcare providers to administer nucleic acid therapeutics through oral delivery.
Contact Information
Website
www.particella.bioCorporate Office
- 665 3rd Street
- Suite 250
- San Francisco, CA 94107
- United States
Corporate Office
- 665 3rd Street
- Suite 250
- San Francisco, CA 94107
- United States
Particella Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 16-Jan-2025 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Private | Completed | Pre-Clinical Trials | ||||
| 9. Later Stage VC | 07-Mar-2023 | Completed | Pre-Clinical Trials | |||
| 8. Later Stage VC (Series A) | 01-Apr-2022 | Completed | Pre-Clinical Trials | |||
| 7. Seed Round | 08-Aug-2018 | Completed | Pre-Clinical Trials | |||
| 6. Seed Round | 22-Dec-2017 | Completed | Pre-Clinical Trials | |||
| 5. Accelerator/Incubator | 07-Sep-2017 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 05-Apr-2017 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 01-Feb-2017 | $5K | Completed | Pre-Clinical Trials | ||
| 2. Accelerator/Incubator | $5K | Completed | Pre-Clinical Trials |
Particella Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Series A-1 | ||||||||
| Seed-1c | ||||||||
| Seed-1b | 518,941 | $0.000100 | $0.04 | $0.48 | $0.48 | 1x | $0.48 | 3.3% |
| Seed-1a | 1,717,621 | $0.000100 | $0.07 | $0.87 | $0.87 | 1x | $0.87 | 10.93% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Particella Comparisons
Industry
Financing
Details
Particella Competitors (33)
One of Particella’s 33 competitors is Adaptimmune Therapeutics, a Formerly VC-backed company based in Abingdon, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| etherna | Formerly VC-backed | Niel, Belgium | ||||
| Carisma Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| Phathom Pharmaceuticals | Formerly VC-backed | Florham Park, NJ | ||||
| BioNTech | Formerly VC-backed | Mainz, Germany |
Particella Signals
Particella Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Transitions First | Venture Capital | Minority | ||
| Berkeley SkyDeck | Accelerator/Incubator | Minority | ||
| Berkeley SkyDeck Fund | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| KdT Ventures | Venture Capital | Minority |
Particella FAQs
-
When was Particella founded?
Particella was founded in 2016.
-
Where is Particella headquartered?
Particella is headquartered in San Francisco, CA.
-
What is the size of Particella?
Particella has 7 total employees.
-
What industry is Particella in?
Particella’s primary industry is Drug Discovery.
-
Is Particella a private or public company?
Particella is a Private company.
-
What is Particella’s current revenue?
The current revenue for Particella is .
-
How much funding has Particella raised over time?
Particella has raised $13M.
-
Who are Particella’s investors?
Transitions First, Berkeley SkyDeck, Berkeley SkyDeck Fund, , and KdT Ventures are 5 of 17 investors who have invested in Particella.
-
Who are Particella’s competitors?
Adaptimmune Therapeutics, etherna, Carisma Therapeutics, Phathom Pharmaceuticals, and BioNTech are some of the 33 competitors of Particella.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process